Principles of autoantibodies as disease-specific markers

Autoimmunity

Volumn 37, Issue 4, 2004, Pages 253-256

  Hawa, M ^a   Beyan, H ^a   Leslie, R D G ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; THYROID ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; CELIAC DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE MARKER; GASTRITIS; HASHIMOTO DISEASE; HUMAN; IMMUNOFLUORESCENCE TEST; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; PRIMARY BILIARY CIRRHOSIS; SENSITIVITY AND SPECIFICITY;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; HUMANS;

EID: 4444364421     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930410001710668     Document Type: Article

References (17)

1. Janeway, C.A. (2001) "How the immune system works to protect the host from infection: a personal view", PNAS 98, 7461-7468,
2. Bach, J.F. (2002) "The effect of infections on susceptibility to autoimmune and allergic diseases", N. Engl. J Med. 347, 911-920.
3. Leslie, R.D.G., Atkinson, M.A. and Notkins, A.L. (1999) "Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes", Diabetologia 42, 3-14.
4. Betterle, C., Volpato, M., Rees, S.B., et al. (1997) "Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease", J Clin. Endocrinol. Metab. 82, 939-942.
5. Maki, M., Mustalahti, K., Kokkonen, J., et al. (2003) "Prevalence of Celiac disease among children in Finland", N Engl J Med. 348, 2517-2524.
6. Bingley, P.J., Bonifacio, E., Williams, A.J., Genovese, S., Bottazzo, G.F. and Gale, E.A. (1997) "Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers", Diabetes 46, 1701-1710.
7. Turner, R., Stratton, I., Horton, V., et al. (1997) "UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK prospective diabetes study group", Lancet 350, 1288-1293.
8. Shmerling, R.H. and Delbanco, T.L. (1991) "The rheumatoid factor: an analysis of clinical utility", Am. J. Med. 91, 528-534.
9. Pearce, E.N., Farwell, A.P. and Braverman, L.E. (2003) "Thyroiditis", N. Engl. J. Med. 348, 2646-2655.
10. Yu, L., Brewer, K.W. and Gates, S. (1999) "DRBI*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease", J. Clin. Endocrinol. Metab. 84, 328-335.
11. Bottazzo, G.F. (1993) "Banting Lecture. On the honey disease. A dialogue with Socrates", Diabetes 42, 778-800.
12. Bingley, P.J., Bonifacio, E. and Mueller, P.W. (2003) "Diabetes antibody standardization program: first assay proficiency evaluation", Diabetes 52, 1128-1136.
13. Kulmala, R, Savola, K., Petersen, J.S., et al. (1998) "Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland study group", J. Clin. Invest. 101, 327-336.
14. Jones, D.E, (2000) "Autoantigens in primary biliary cirrhosis", J Clin Pathol. 53, 813-821.
15. Jenkins, R.C. and Weetman, A.P. (2002) "Disease associations with autoimmune thyroid disease", Thyroid 12, 977-988.
16. Berger, T., Rubner, R., Schautzer, F., Egg, R., Ulmer, H., Mayringer, I., Dilitz, E., Deisenhammer, F. and Reindl, M. (2003) "Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event", N. Engl. J. Med. 349, 139-145.
17. Toh, B.H., Van Driel, I.R. and Gleeson, P.A. (1997) "Pernicious anemia", N. Engl. J. Med. 337, 441-1448.